Biotie will issue 161,448,371 shares to acquire Switzerland-based Synosia.

Texas Health Resources, provided $25m to MedSynergies after acquiring MedicalEdge at the start of the month and spinning off the PhyServe division.

Synthetic Genomics had in June made an initial close at $10m from one investor out of a targeted $50m but has now gathered $35m from six backers.

Merck Serono Ventures joined venture capital firms Sunstone Capital, and BioMedPartners as new investors in Vaximm's latest $8m round.

News provider Fortune, which revealed a $66m initial round of fundraising for Oxford Bioscience Partners, said Hanwha would help the US firm in Korea.

23andMe previously raised $22m in its series C round from a consortium including new investor Johnson & Johnson Development Corporation and has added $9m from MPM Capital.

CardioInsight Technologies raises more than $10m from DVX and venture capital firms Draper Triangle Ventures, which led the financing, and Case Technology Ventures, which makes pre-seed stage investments out of Case Western Reserve University.

Italian insurer invested through its Generali Financial and BSI subsidiaries in VisionCare's $31m series E round.

A regulatory filing said six investors had provided $4.6m for Neuroptix.

EyeGate Pharmaceuticals extends D round to $28.5m.